0001437749-19-006888.txt : 20190410 0001437749-19-006888.hdr.sgml : 20190410 20190410165549 ACCESSION NUMBER: 0001437749-19-006888 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190408 FILED AS OF DATE: 20190410 DATE AS OF CHANGE: 20190410 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: McLaughlin Matthew T E CENTRAL INDEX KEY: 0001773442 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36200 FILM NUMBER: 19742118 MAIL ADDRESS: STREET 1: C/O OXFORD IMMUNOTEC GLOBAL PLC STREET 2: 94C INNOVATION DRIVE, MILTON PARK CITY: ABINGDON, OXFORDSHIRE STATE: X0 ZIP: OX14 4RZ ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Oxford Immunotec Global PLC CENTRAL INDEX KEY: 0001586049 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 94C INNOVATION DRIVE STREET 2: MILTON PARK CITY: ABINGDON STATE: X0 ZIP: OX14 4RZ BUSINESS PHONE: 44 01235 442780 MAIL ADDRESS: STREET 1: 94C INNOVATION DRIVE STREET 2: MILTON PARK CITY: ABINGDON STATE: X0 ZIP: OX14 4RZ 4 1 rdgdoc.xml FORM 4 X0306 4 2019-04-08 0001586049 Oxford Immunotec Global PLC OXFD 0001773442 McLaughlin Matthew T E C/O OXFORD IMMUNOTEC GLOBAL PLC 94C INNOVATION DRIVE ABINGDON, OXFORDSHIRE X0 OX14 4RZ UNITED KINGDOM 1 Chief Financial Officer Ordinary Shares 2019-04-08 4 A 0 26612 0 A 26612 D Share Option (Right to Buy) 15.97 2019-04-08 4 A 0 57108 0 A 2029-04-08 Ordinary Shares 57108 57108 D Options granted under Issuer's 2013 Share Incentive Plan. Options will become exercisable ratably on the anniversary of the vesting start date from May 1, 2020 through May 1, 2023. /s/ Matthew T E McLaughlin 2019-04-10